Colonic Neoplasms × Sarcoma × 30 days × Clear all
NCT03093116 2026-05-27

TRIDENT-1

Turning Point Therapeutics, Inc.

Phase 1/2 Recruiting
500 enrolled 2 FDA
NCT02012699 2026-05-05

iCaRe2

University of Nebraska

Recruiting
999,999 enrolled